MA49393A - Poly(phosphoesters) destinés à l'administration d'acides nucléiques - Google Patents
Poly(phosphoesters) destinés à l'administration d'acides nucléiquesInfo
- Publication number
- MA49393A MA49393A MA049393A MA49393A MA49393A MA 49393 A MA49393 A MA 49393A MA 049393 A MA049393 A MA 049393A MA 49393 A MA49393 A MA 49393A MA 49393 A MA49393 A MA 49393A
- Authority
- MA
- Morocco
- Prior art keywords
- phosphoesters
- administration
- poly
- intended
- nucleic acids
- Prior art date
Links
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G79/00—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/53—Ligases (6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F293/00—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G79/00—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule
- C08G79/02—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule a linkage containing phosphorus
- C08G79/04—Phosphorus linked to oxygen or to oxygen and carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762518313P | 2017-06-12 | 2017-06-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA49393A true MA49393A (fr) | 2020-04-22 |
Family
ID=62909585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA049393A MA49393A (fr) | 2017-06-12 | 2018-06-11 | Poly(phosphoesters) destinés à l'administration d'acides nucléiques |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US11530298B2 (fr) |
| EP (2) | EP3638716B1 (fr) |
| MA (1) | MA49393A (fr) |
| WO (1) | WO2018231709A1 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8853377B2 (en) * | 2010-11-30 | 2014-10-07 | Shire Human Genetic Therapies, Inc. | mRNA for use in treatment of human genetic diseases |
| AU2019271132B2 (en) * | 2018-05-15 | 2026-02-05 | Translate Bio, Inc. | Subcutaneous delivery of messenger RNA |
| KR20230118715A (ko) | 2020-10-14 | 2023-08-11 | 조지 메이슨 리서치 파운데이션 인코포레이티드 | 이온화 가능 지질 및 이의 제조 및 사용 방법 |
| IL309505A (en) | 2021-09-03 | 2024-02-01 | CureVac SE | Novel lipid nanoparticles for delivery of nucleic acids |
| US20250027108A1 (en) | 2021-10-29 | 2025-01-23 | CureVac SE | Improved circular rna for expressing therapeutic proteins |
| US20250099614A1 (en) | 2022-01-28 | 2025-03-27 | CureVac SE | Nucleic acid encoded transcription factor inhibitors |
| CA3248209A1 (fr) | 2022-05-25 | 2023-11-30 | CureVac SE | Vaccin à base d’acide nucléique codant pour un polypeptide antigénique fimh d’escherichia coli |
| EP4608442A1 (fr) | 2022-10-28 | 2025-09-03 | GlaxoSmithKline Biologicals S.A. | Vaccin à base d'acide nucléique |
| JP2026509258A (ja) | 2023-03-08 | 2026-03-17 | キュアバック エスイー | 核酸送達のための新規な脂質ナノ粒子製剤 |
| WO2024230934A1 (fr) | 2023-05-11 | 2024-11-14 | CureVac SE | Acide nucléique thérapeutique pour le traitement de maladies ophtalmiques |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5132418A (en) | 1980-02-29 | 1992-07-21 | University Patents, Inc. | Process for preparing polynucleotides |
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US4500707A (en) | 1980-02-29 | 1985-02-19 | University Patents, Inc. | Nucleosides useful in the preparation of polynucleotides |
| US4415732A (en) | 1981-03-27 | 1983-11-15 | University Patents, Inc. | Phosphoramidite compounds and processes |
| US4668777A (en) | 1981-03-27 | 1987-05-26 | University Patents, Inc. | Phosphoramidite nucleoside compounds |
| US4973679A (en) | 1981-03-27 | 1990-11-27 | University Patents, Inc. | Process for oligonucleo tide synthesis using phosphormidite intermediates |
| US4373071A (en) | 1981-04-30 | 1983-02-08 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US4401796A (en) | 1981-04-30 | 1983-08-30 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US5153319A (en) | 1986-03-31 | 1992-10-06 | University Patents, Inc. | Process for preparing polynucleotides |
| US5047524A (en) | 1988-12-21 | 1991-09-10 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| US5262530A (en) | 1988-12-21 | 1993-11-16 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| US6184389B1 (en) | 1994-01-11 | 2001-02-06 | Isis Pharmaceuticals, Inc. | Combinatorial libraries having aminodiol monomer subunits |
| US5700642A (en) | 1995-05-22 | 1997-12-23 | Sri International | Oligonucleotide sizing using immobilized cleavable primers |
| US6805876B2 (en) | 2000-03-10 | 2004-10-19 | Johns Hopkins University | Phosphate based biodegradable polymers |
| US7345138B2 (en) | 2001-05-14 | 2008-03-18 | Johns Hopkins Singapore Pte Ltd. | Biodegradable polyphosphates for controlled release of bioactive substances |
| WO2008016473A2 (fr) | 2006-07-28 | 2008-02-07 | Applera Corporation | ANALOGUES DE COIFFES DE NUCLÉOTIDE D'ARNm |
| WO2009058911A2 (fr) | 2007-10-31 | 2009-05-07 | Applied Biosystems Inc. | Préparation et isolement d'un arnm coiffé en 5' |
| ES2647832T3 (es) | 2013-03-14 | 2017-12-26 | Translate Bio, Inc. | Ácidos ribonucleicos con nucleótidos modificados con 4-tio y procedimientos relacionados |
| BR112020021054A2 (pt) | 2018-04-25 | 2021-02-17 | Ethris Gmbh | composição, processo para a preparação de uma composição, e, composições sólida e para uso |
-
2018
- 2018-06-11 EP EP18740671.5A patent/EP3638716B1/fr active Active
- 2018-06-11 US US16/621,045 patent/US11530298B2/en active Active
- 2018-06-11 WO PCT/US2018/036920 patent/WO2018231709A1/fr not_active Ceased
- 2018-06-11 EP EP22150237.0A patent/EP4047039A1/fr not_active Withdrawn
- 2018-06-11 MA MA049393A patent/MA49393A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US11530298B2 (en) | 2022-12-20 |
| US20200277446A1 (en) | 2020-09-03 |
| WO2018231709A1 (fr) | 2018-12-20 |
| EP3638716B1 (fr) | 2022-01-05 |
| EP3638716A1 (fr) | 2020-04-22 |
| EP4047039A1 (fr) | 2022-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA47824A (fr) | Administration polyanionique d'acides nucléiques | |
| MA52709A (fr) | Administration d'adn | |
| CL2020002043A1 (es) | Métodos y composiciones para la entrega de proteínas terapeuticas. | |
| EP3775202A4 (fr) | Agents thérapeutiques à base d'acides nucléiques | |
| EP3408389A4 (fr) | Isotachophorèse destinée à la purification d'acides nucléiques | |
| PT3506909T (pt) | Análogos de 4¿-fosfato e oligonucleótidos compreendendo os mesmos | |
| MA46466A (fr) | Formulations pharmaceutiques de protéines à viscosité réduite | |
| EP3405247A4 (fr) | Administration de botuline à l'aide de matrices de micro-aiguilles | |
| EP3452003A4 (fr) | Forme pharmaceutique à libération contrôlée | |
| EP3294212A4 (fr) | Administration de médicament à partir d'hydrogels | |
| EP3431075C0 (fr) | Forme galénique d'édaravone | |
| EP3422945A4 (fr) | Immunothérapie anticancéreuse améliorée par le biais d'une administration par patch à micro-aiguilles | |
| EP3368555A4 (fr) | Protéines à double fonction et composition pharmaceutique comprenant ces dernières | |
| EP3435978A4 (fr) | Système d'administration | |
| EP3454839A4 (fr) | Véhicule d'administration biologique à base d'hydrogel | |
| EP3416647A4 (fr) | Iminopyrimidinones substituées par n3 à titre d'agents antipaludéens | |
| MA45472A (fr) | Systèmes d'administration pour la libération contrôlée de médicaments | |
| ITUA20161408A1 (it) | Macchina e procedimento per la preparazione di medicamenti intravenosi | |
| EP3525841A4 (fr) | Micro-dispositif d'administration | |
| EP3643353A4 (fr) | Robot d'administration de médicament | |
| EP3358619A4 (fr) | Élément d'imagerie à semi-conducteurs rétroéclairé | |
| EP3413909A4 (fr) | Administration sous-cutanée d'adénovirus à double ciblage | |
| EP3550606A4 (fr) | Élément d'imagerie à semiconducteurs | |
| MA46621A (fr) | Traitements combinés comprenant l'administration d'imidazopyrazinones | |
| EP3618723A4 (fr) | Cathéter d'imagerie |